Background Surgical resection is the main treatment for symptomatic nonfunctioning
pituitary adenomas (NFPA). We aimed to analyze the impact of surgical approach …

Background The subcutaneous implantable cardioverter–defibrillator (ICD) is associated
with fewer lead-related complications than a transvenous ICD; however, the subcutaneous …

Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) is developed to
overcome lead-related complications and systemic infections, inherent to transvenous ICD …

Background Implantable cardioverter-defibrillator (ICD) shocks are associated with higher
rates of mortality and reduced quality of life. In this study we aimed to investigate the …

Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed
to avoid complications related to transvenous implantable cardioverter-defibrillator (TV-ICD) …

Background To assess the risk of unsuccessful conversion of ventricular fibrillation during
defibrillation testing (DFT) with the subcutaneous implantable cardioverter-defibrillator (S …

The field of cardiac pacing has been defined by constant development to provide
efficacious, safe, and reliable therapy. Traditional pacing utilizes transvenous leads, which …

In heart failure with reduced ejection fraction (HFrEF), the presence of concomitant chronic
kidney disease (CKD) predicts poorer cardiovascular outcomes, more aggravated heart …

Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) has been
designed to overcome lead-related complications and device endocarditis. Lacking the …

There has been much controversy regarding the order in which cytoreductive nephrectomy
(CN) and systemic therapy (ST) are applied for patients with metastatic renal cell carcinoma …